Category Archives: Nanotechnology

Sri Lanka will be a destination for nanotechnology research and development, said Chairman (SLINTEC) Dr. Mahesh Amalean, at a ceremony to launch the partnership between SLINTEC and Nagarjuna Fertilisers and Chemicals Ltd,(NFCL), India to develop the next generation nanotechnology-based plant nutrition solutions.

Full Story

The number of tourists arrivals during the first two months of this year recorded a 21 percent growth with 169,423 visitors compared to 139,994 recorded in the corresponding months last year. Latin America and the Caribbean market dominated arrivals with a 83.8 percent growth notching 430 visitors compared to 234 recorded in the corresponding period last year.

Full Story

Standard Chartered Bank introduced SME banking to Sri Lanka last week. It offers facilities and tailor made solutions that are commonly accessible by large corporate and (MNCs), to the Sri Lankan SME sector covering four the areas of ; working capital management, business protection, yield enhancement and business expansion.

Full Story

A single visa system is important, to achieve the objectives of the South Asian Subregion Tourism Forum (SASTF) said the director of Shangri la Tours and the President of Nepal Tours Association, Ashok Polkharel told SASTF in Colombo last week.

Full Story

Sri Lanka Telecom (SLT), launched a Technology Experience Centre a platform where enterprise and SME customers can experience first-hand, the companys enhanced services provided through state-of-the-art technology. The one-of-a-kind SLT Technology Experience Centre is at the Companys head office premises at Fort, Colombo.

Full Story

See more here:
Sri Lanka heralds nanotechnology

Public release date: 14-Mar-2012 [ | E-mail | Share ]

Contact: James Cohen cohen@kavlifoundation.org The Kavli Foundation

Imagine a test that sifts through millions of molecules in a drop of a patient's blood to detect a telltale protein signature of a cancer subtype, or a drug ferry that doesn't release its toxic contents until it slips inside cancer cells.

These and other nanotechnologies could be game changers in how we diagnose, monitor and treat cancer, according to Mark Davis, Professor of Chemical Engineering at the California Institute of Technology, and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope.

Davis discussed how nanotechnology was revolutionizing the battle against cancer when he gave the Fred Kavli Distinguished Lectureship in Nanoscience at the fall meeting of the Materials Research Society a lecture that has since become available on the web. Focusing on nanoparticles, Davis said during the lecture, "We're trying to create these nanoscale particles for solid tumors [and] there really is, in my opinion, a very high potential to creat new types of therapies and allow people to have a high quality of life."

Later discussing these advances with three other researchers, Davis elaborated, saying, "What's really exciting to me is the patient evidence that reveal nanoparticles are actually going into tumor cells and releasing their payloads [We're also] starting to see preliminary evidence that these therapies are having some effects in patients while also giving them a high quality of life."

According to Michael Phelps, Norton Simon Professor, and Chair of Molecular and Medical Pharmacology at the University of California Los Angeles, another promising technology is PET molecular imaging probes, which can rapidly search for cancer throughout all tissues of the body, as well as characterize each cancer lesion it detects within an individual patient. "All cancer treatments are in need of better molecular diagnostics... to better characterize the biology of cancer," said Phelps.

"Nanotechnology is an amazing discovery tool ...giving us a new set of eyes that are opening up a whole new world," said James Heath, Professor of Chemistry at Caltech and a founding Board member of Caltech's Kavli Nanoscience Institute. "All evidence suggests that when you do careful engineering of these nanotechnologies, the benefits are great."

Anna Barker agreed. The Former Deputy Director of the National Cancer Institute (NCI) and current Director of Arizona State University's Transformative Healthcare Networks, she said, "The nanotechnologies that are currently in use in the cancer community are actually making cancer therapies safer. They are uniformly increasing the efficiency, while reducing the toxicity for patients."

###

Read more from the original source:
Fighting cancer with nanotechnology

DURHAM, N.C.--(BUSINESS WIRE)--

Cutting-edge artists from across the world will participate in the Art of the Small, a juried exhibition held in conjunction with the Nanotech Commercialization Conference (http://www.nanoevent.org), April 4-5, 2012 at the American Tobacco Campus, in Durham, NC. Artists were invited through an open call to exhibit work inspired by nanotechnology, nanobiotech, biotechnology, genomics, DNA, and genetics. Winning artists in several categories will receive a cash award to be announced at the awards and VIP reception. The art exhibition is open to the public on Wednesday, April 4, 2012 from 5 to 7pm at Bay 7 of the American Tobacco Campus in Durham, NC.

Nanotechnology is rapidly transforming industries from medicine to manufacturing to energy. Since the passage of the 21st Century Nanotechnology R&D Act by the U.S. Congress, billions of dollars have been invested in the science of nanotechnology which is rapidly becoming the business of nanotechnology, creating thousands of new start-ups, bolstering nearly every industry across the globe, creating jobs, and bringing life changing innovations to market. The field has also inspired a new category of art, whereby the forms and images of the atomic world are being transformed into new forms of art by the scientific and artistic communities.

The show will be curated by artist and NanoBusiness Alliance founder, F. Mark Modzelewski, an installation artist, who has shown at galleries around the world and curated numerous shows in Boston, Washington DC, and New York. A panel of expert judges drawn from the worlds of art, science, and science communication will select the winning entries. The art will be judged on three key criteria: depiction and representation of the theme, creativity of image representation and innovation in style or technique.

Its inspiring to see these inventive and expressive worlds collide to create new art forms, said Griffith Kundahl, Executive Director of The Center of Innovation for Nanobiotechnology (COIN). We are delighted to support and showcase this artwork at this nanotech conference in Durham, a city well-known for both the arts and sciences.

My career has combined duel passions for art and technology, noted curator F. Mark Modzelewski. I am excited by this opportunity to work with COIN to expose leaders in the nanotech and biotech communities to leading artists from around the world that are taking science and transforming it into art.

Dozens of entries have flooded in from leading figures in the art and science fields, from countries ranging from the United States to Cyprus to South Korea. Following the conference, images of the works from the exhibition will appear in an online gallery supported by COIN for a period of 36 months.

Sponsors for the event and exhibition include:

NanoBCA: The NanoBusiness Commercialization Association (NanoBCA) http://www.nanobca.org is a 501(c)(6) trade organization lead by Vincent Caprio http://www.vincentcaprio.org, Executive Director, dedicated to promoting the commercialization of nanotechnology and helping companies bring affordable, life-improving nanotech products to the market. Founded in 2001, the organization has been at the forefront of policy and advocacy for the nanotechnology community for over a decade.

NCBST: In 1963, the North Carolina General Assembly established the North Carolina Board of Science & Technology to encourage, promote, and support scientific, engineering, and industrial research applications in North Carolina. To meet these goals, the Board works to investigate new areas of emerging science and technology and conducts studies on the competitiveness of state industry and research institutions in these fields. The Board also works with the General Assembly and the Governor to put into place the infrastructure that keeps North Carolina on the cutting edge of science and technology.

Read more:
Nanotechnology Art Exhibition at the Nanotech Commercialization Conference

Newswise Imagine a test that sifts through millions of molecules in a drop of a patient's blood to detect a telltale protein signature of a cancer subtype, or a drug ferry that doesn't release its toxic contents until it slips inside cancer cells.

These and other nanotechnologies could be game changers in how we diagnose, monitor and treat cancer. To more fully understand the impact, The Kavli Foundation held a roundtable teleconference with four pioneers in the field.

* Anna Barker - Former Deputy Director of the National Cancer Institute (NCI) and current Director of Arizona State University's Transformative Healthcare Networks; * Mark E. Davis - Professor of Chemical Engineering at the California Institute of Technology (Caltech), and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope; * James Heath - Professor of Chemistry at Caltech and a founding Board member of Caltech's Kavli Nanoscience Institute; * Michael Phelps - Norton Simon Professor, and Chair of Molecular and Medical Pharmacology at the University of California Los Angeles.

The researchers discussed how nanotechnology holds the promise of revolutionizing the way medicine wages war against cancer, from providing new ways to combine drugs to delivering gene-silencing therapeutics for cancer cells. "What's really exciting to me is the patient evidence that reveal nanoparticles are actually going into tumor cells and releasing their payloads," said Davis. "[We're also] starting to see preliminary evidence that these therapies are having some effects in patients while also giving them a high quality of life."

Another promising technology is PET molecular imaging probes, which can rapidly search for cancer throughout all tissues of the body, as well as characterize each cancer lesion it detects within an individual patient. "All cancer treatments are in need of better molecular diagnostics... to better characterize the biology of cancer," said Phelps.

These technologies add a layer of precision, insight and invention to cancer treatment that can be transformative. Said Heath, "Nanotechnology is an amazing discovery tool ...giving us a new set of eyes that are opening up a whole new world." Regarding the future, he added, "All evidence suggests that when you do careful engineering of these nanotechnologies, the benefits are great." Barker agreed. "The nanotechnologies that are currently in use in the cancer community are actually making cancer therapies safer. They are uniformly increasing the efficiency, while reducing the toxicity for patients."

For the complete dialogue, visit: http://www.kavlifoundation.org/science-spotlights/nanoscience-fighting-cancer-nanotechnology

Read more:
Fighting Cancer with Nanotechnology - Roundtable Discussion

DUBLIN--(BUSINESS WIRE)--

Research and Markets(http://www.researchandmarkets.com/research/7d08dd/nanotechnology_for) has announced the addition of the "Nanotechnology for Medical Diagnostics" report to their offering.

Cientifica's "Nanotechnology for Medical Diagnostics" looks at emerging nanoscale technologies

The healthcare market, poised to see some of the earliest benefits of nanotechnology over the next decade, will be one of nanotech's highest growth sectors. Technology is advancing on all fronts, from highly affordable point-of-care diagnostics with the potential to make mass screening and early detection of disease possible, through to highly targeted therapeutics with drugs being delivered and released only where needed.

Nanotechnology promises to revolutionize medical diagnostics: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

The implications are enormous, said Tim Harper, CEO of Cientifica Ltd. Diagnostic tools using nanotechnology are pushing the envelope in terms of speed, sensitivity and cost and are beginning to have an impact on almost every sector. In 10 years' time the idea of taking a blood sample and sending it away to be analyzed will be seem as old fashioned as buying music from a 'record' store.

Cientifica estimates medical imaging is the sector showing the highest growth and impact of nanomaterials. Already a $1.7-billion market, with gold nanoparticle applications accounting for $959 million, imaging will continue to be the largest nanodiagnostics sector, with gold nanoparticles, quantum dots and nanobiosensors all easily exceeding $10 billion.

Getting onboard with the right technology at the right time is crucial, said Harper. The use of exosomes in diagnosis, for instance, a relatively new technique and a tiny market, is set to reach close to half a billion dollars by 2021.

Nanotech enabled medical diagnostics promise to improve just about everything that can be improved from a diagnostics point of view: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

This report provides a market numbers for the nanotech enabled medical diagnostic market between 2000-2010 and a market forecast for the period 2011-2021.

Read more:
Research and Markets: Nanotechnology for Medical Diagnostics Report - Nanodiagnostics will be a $50-Billion Market by ...

SANTA CLARA, Calif., March 13, 2012 /PRNewswire/ -- Crocus Technology, a leading developer of magnetically enhanced semiconductors, today announced that it has signed a research and development agreement with Kintech Lab, a leading researchcompany in Russia, specializing in the development of advanced methodologies and multi-scale software tools for modeling complex electronics and other physical phenomena.

Under the terms of the agreement, Kintech Lab will develop a modeling platform and perform complete physical simulation of Crocus' TAS MLU memory cell.The simulation results will provide deeper understanding of the nano-scale performance of the TAS MLU cell and enable Crocus to optimize materials and processing for enhanced functionality and reliability.

"Crocus is delighted to collaborate with Kintech Lab on advanced modeling of our MLU technology," said Ken MacKay, Crocus' director of Magnetic Technology Engineering. "Kintech's world-class expertise in physics and modeling will be instrumental to Crocus as we migrate our process technologies to state-of-the-art lithography."

In May 2011, Crocus announced that it will invest over $5 million into Russian research organizations to develop advanced technology and manufacturing solutions. This partnership with Kintech represents the first step towards achieving that objective, as set forth in Crocus' agreement with RUSNANO to develop advanced magnetic nanotechnology manufacturing and science in Russia.

"This initiative with Crocus is setting the foundation for model-based advanced nano-magnetic research in Russia," said Boris Potapkin, chief executive officer of Kintech Laboratory. "We look forward to working with Crocus on solving problems essential to the deployment of leading edge technologies."

About CrocusCrocus is a leading developer of magnetic semiconductor technology for dense, non-volatile, high-speed, scalable chip solutions used in general and special purpose applications. The company's Magnetic Logic Unit (MLU) architecture, featuring a revolutionary self-reference technique, is a scalable evolution of Crocus' patented Thermally Assisted Switching (TAS) technology. MLU enables practical implementation of advanced magnetic logic and memory capabilities. Crocus' first generation magnetic technology was originally conceived at the Grenoble, France-based Spintec, a world leading magnetic research laboratory affiliated with two leading French labs, CEA and CNRS. It was further developed for production at SVTC in California and is in its final phase of implementation at Tower Jazz semiconductor. In October 2011, Crocus announced a joint development agreement with IBM to further advance the technology, focusing on advanced development of the MLU architecture. Crocus' technology is covered by a comprehensive patent portfolio. In May 2011, Crocus and RUSNANO formed a joint venture, Crocus Nano Electronics (CNE), to build and operate an advanced manufacturing facility for magnetic semiconductors. Find Crocus at: http://www.crocus-technology.com

About Kintech LabKintech Lab develops and implements integrated computer simulation software and information systems for first principles-based predictive multi-scale modeling and analysis of the properties of new processes, materials and devices. Kintech Lab carries out scientific research projects in the fields of combustion and plasma technologies, catalysis, advanced energy systems including fuel and solar cells, batteries, light sources, nanotechnologies and new materials. In 2011, Kintech Lab obtained status as a Skolkovo resident, and in January 2012 was awarded with a $1.3 million grant supporting a projected titled, 'Technique of predictive multi-scale modeling and mechanistic development of processes for efficient power engineering, chemical industry and the design of new materials.' For more information about Kintech Lab, visit http://www.kintechlab.com.

Read the rest here:
Crocus and Kintech Sign Agreement to Perform Nanotechnology R&D in Russia